TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A RCT to Test the Effectiveness of a Telephone Intervention to Improve the Mental Health of Community Dwelling Women Abused by Their Intimate Partners
Brief Summary: The purpose of this study is to determine if a telephone social support and empowerment intervention is more effective than usual community services in improving the mental health of community-dwelling women abused by their intimate partners.


Options:
A: Arm Label: Waitlist-Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Common Elements Treatment Approach; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): Common Elements Treatment Approach
B: Arm Label: Family-Focused Psychosocial Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention; Assigned to Arm(s): Family-Focused Psychosocial Intervention
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: NET | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: NET; Assigned to Arm(s): A
D: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A RCT to Test the Effectiveness of a Telephone Intervention to Improve the Mental Health of Community Dwelling Women Abused by Their Intimate Partners
Brief Summary: The purpose of this study is to determine if a telephone social support and empowerment intervention is more effective than usual community services in improving the mental health of community-dwelling women abused by their intimate partners.


Options:
A: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
B: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services
C: Intervention Type: DEVICE; Name: Interactive computer based health-risk survey before doctor's visit; Assigned to Arm(s): N/A
D: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A RCT to Test the Effectiveness of a Telephone Intervention to Improve the Mental Health of Community Dwelling Women Abused by Their Intimate Partners
Brief Summary: The purpose of this study is to determine if a telephone social support and empowerment intervention is more effective than usual community services in improving the mental health of community-dwelling women abused by their intimate partners.


Options:
A: Arm Label: Brief Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement Therapy | Arm Label: Assessed Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Contact Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement Therapy; Assigned to Arm(s): Brief Intervention Group
B: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services
C: Arm Label: NFP + IPV intervention; Type: EXPERIMENTAL; Interventions: Behavioral: NFP + IPV intervention | Arm Label: NFP (standard care); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: NFP + IPV intervention; Assigned to Arm(s): NFP + IPV intervention
D: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: RHANI Wives Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: RHANI WIves | Intervention Type: BEHAVIORAL; Name: RHANI WIves; Assigned to Arm(s): RHANI Wives Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A RCT to Test the Effectiveness of a Telephone Intervention to Improve the Mental Health of Community Dwelling Women Abused by Their Intimate Partners
Brief Summary: The purpose of this study is to determine if a telephone social support and empowerment intervention is more effective than usual community services in improving the mental health of community-dwelling women abused by their intimate partners.


Options:
A: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
B: Arm Label: Internet Based Safety Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based safety decision aid | Arm Label: Control Website; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care Safety Plan | Intervention Type: BEHAVIORAL; Name: Internet-based safety decision aid; Assigned to Arm(s): Internet Based Safety Decision Aid | Intervention Type: BEHAVIORAL; Name: Usual Care Safety Plan; Assigned to Arm(s): Control Website
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: RHANI Wives Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: RHANI WIves | Intervention Type: BEHAVIORAL; Name: RHANI WIves; Assigned to Arm(s): RHANI Wives Intervention
D: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A RCT to Test the Effectiveness of a Telephone Intervention to Improve the Mental Health of Community Dwelling Women Abused by Their Intimate Partners
Brief Summary: The purpose of this study is to determine if a telephone social support and empowerment intervention is more effective than usual community services in improving the mental health of community-dwelling women abused by their intimate partners.


Options:
A: Arm Label: Standard Positive Prevention Counselling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational intervention counselling plus SPP | Arm Label: Alcohol Motivational intervention counselling plus SPP; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational intervention counselling plus SPP | Intervention Type: BEHAVIORAL; Name: Motivational intervention counselling plus SPP; Assigned to Arm(s): Alcohol Motivational intervention counselling plus SPP, Standard Positive Prevention Counselling
B: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
C: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services
D: Arm Label: Enhanced Usual Care (EUC); Type: OTHER; Interventions: Other: EUC | Arm Label: THPP-P; Type: EXPERIMENTAL; Interventions: Behavioral: THPP-P, Other: EUC | Intervention Type: BEHAVIORAL; Name: THPP-P; Assigned to Arm(s): THPP-P | Intervention Type: OTHER; Name: EUC; Assigned to Arm(s): Enhanced Usual Care (EUC), THPP-P

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of Dietary Prevention of Type 1 Diabetes Associated Beta-cell Autoimmunity in Children at Genetic Risk
Brief Summary: The purpose of this study is to determine whether weaning to whey-based hydrolysed formula or essentially bovine insulin free whey-based FINDIA formula instead of standard cow's milk based formula is effective in the prevention of type 1 diabetes associated beta-cell autoimmunity in children at genetic risk of type 1 diabetes.


Options:
A: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil LIPIL with iron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Good Start Supreme with DHA and ARA | Intervention Type: OTHER; Name: Enfamil LIPIL with iron; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Good Start Supreme with DHA and ARA; Assigned to Arm(s): 2
C: Arm Label: Cow's milk formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Bovine insulin-free whey based formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Whey-based hydrolysed formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Cow's milk formula; Assigned to Arm(s): Bovine insulin-free whey based formula, Cow's milk formula, Whey-based hydrolysed formula
D: Arm Label: Hydrolysed infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Hydrolysed infant formula | Arm Label: Nonhydrolysed infant formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nonhydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Hydrolysed infant formula; Assigned to Arm(s): Hydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Nonhydrolysed infant formula; Assigned to Arm(s): Nonhydrolysed infant formula

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of Dietary Prevention of Type 1 Diabetes Associated Beta-cell Autoimmunity in Children at Genetic Risk
Brief Summary: The purpose of this study is to determine whether weaning to whey-based hydrolysed formula or essentially bovine insulin free whey-based FINDIA formula instead of standard cow's milk based formula is effective in the prevention of type 1 diabetes associated beta-cell autoimmunity in children at genetic risk of type 1 diabetes.


Options:
A: Arm Label: extensively hydrolyzed casein formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: dietary intervention | Arm Label: cow's milk based infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: dietary intervention | Intervention Type: DIETARY_SUPPLEMENT; Name: dietary intervention; Assigned to Arm(s): cow's milk based infant formula, extensively hydrolyzed casein formula
B: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula
C: Arm Label: Cow's milk formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Bovine insulin-free whey based formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Whey-based hydrolysed formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Cow's milk formula; Assigned to Arm(s): Bovine insulin-free whey based formula, Cow's milk formula, Whey-based hydrolysed formula
D: Arm Label: Hydrolysed infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Hydrolysed infant formula | Arm Label: Nonhydrolysed infant formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nonhydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Hydrolysed infant formula; Assigned to Arm(s): Hydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Nonhydrolysed infant formula; Assigned to Arm(s): Nonhydrolysed infant formula

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of Dietary Prevention of Type 1 Diabetes Associated Beta-cell Autoimmunity in Children at Genetic Risk
Brief Summary: The purpose of this study is to determine whether weaning to whey-based hydrolysed formula or essentially bovine insulin free whey-based FINDIA formula instead of standard cow's milk based formula is effective in the prevention of type 1 diabetes associated beta-cell autoimmunity in children at genetic risk of type 1 diabetes.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil LIPIL with iron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Good Start Supreme with DHA and ARA | Intervention Type: OTHER; Name: Enfamil LIPIL with iron; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Good Start Supreme with DHA and ARA; Assigned to Arm(s): 2
B: Arm Label: Group EEEEEEE; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil, milk-based formula | Arm Label: Group ENEEEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group EENEEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group EEENEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group ENNNEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group NNNNNNN; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Intervention Type: OTHER; Name: Nutramigen (Flavor and Type of Infant Formula); Assigned to Arm(s): Group EEENEEE, Group EENEEEE, Group ENEEEEE, Group ENNNEEE, Group NNNNNNN | Intervention Type: OTHER; Name: Enfamil, milk-based formula; Assigned to Arm(s): Group EEEEEEE
C: Arm Label: Cow's milk formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Bovine insulin-free whey based formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Whey-based hydrolysed formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Cow's milk formula; Assigned to Arm(s): Bovine insulin-free whey based formula, Cow's milk formula, Whey-based hydrolysed formula
D: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase IV Study on the Effects of Sildenafil in Combination With Pulmonary Rehabilitation Program on Exercise Tolerance in Patients With COPD and Pulmonary Hypertension
Brief Summary: Sildenafil is a phosphodiesterase-5 inhibitor that has been approved for the treatment of pulmonary arterial hypertension with orphan drug designation. Sildenafil modulates the nitric oxide (NO) pathway in the vessel wall. Since this pathway is impaired in pulmonary arteries of patients with pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD), the investigators hypothesized that sildenafil might improve pulmonary hemodynamics and increase exercise tolerance in this condition.


Options:
A: Arm Label: Sildenafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sildenafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Sildenafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Tadalafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tadalafil, placebo | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Tadalafil, placebo | Intervention Type: DRUG; Name: Tadalafil, placebo; Assigned to Arm(s): Tadalafil, placebo
C: Arm Label: Sildenafil plus pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Drug: Sildenafil | Arm Label: Placebo plus pulmonary rehabilitation; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Sildenafil plus pulmonary rehabilitation | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo plus pulmonary rehabilitation
D: Arm Label: 20 mg tadalafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 40 mg tadalafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 20 mg tadalafil | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 40 mg tadalafil

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel Group, Efficacy and Safety Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
Brief Summary: The purpose of this study is to evaluate the effects of oral lixivaptan capsules in patients with congestive heart failure.


Options:
A: Intervention Type: DRUG; Name: satavaptan (SR121463B); Assigned to Arm(s): N/A
B: Arm Label: Lixivaptan; Type: EXPERIMENTAL; Interventions: Drug: Lixivaptan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lixivaptan; Assigned to Arm(s): Lixivaptan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: Tolvaptan; Assigned to Arm(s): N/A
D: Arm Label: Tolvaptan; Type: EXPERIMENTAL; Interventions: Drug: Tolvaptan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tolvaptan; Assigned to Arm(s): Tolvaptan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice Multinational, Prospective, Non-randomized, Multi-centre, Non-interventional Trial
Brief Summary: To evaluate the clinical performance of the PRO-Kinetic ENERGY® coronary bare metal stent system in a patient population within that defined in the Instructions for Use.


Options:
A: Arm Label: ENERGY-Population; Type: N/A; Interventions: Device: Pro Kinetic Energy bare metal stent | Intervention Type: DEVICE; Name: Pro Kinetic Energy bare metal stent; Assigned to Arm(s): ENERGY-Population
B: Arm Label: Conventional PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: Percutaneous transluminal angioplasty (PTA) | Arm Label: Drug coated balloon; Type: EXPERIMENTAL; Interventions: Combination Product: DCB | Intervention Type: DEVICE; Name: Percutaneous transluminal angioplasty (PTA); Assigned to Arm(s): Conventional PTA | Intervention Type: COMBINATION_PRODUCT; Name: DCB; Assigned to Arm(s): Drug coated balloon
C: Arm Label: standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: nitinol stent implantation | Arm Label: DEB; Type: EXPERIMENTAL; Interventions: Device: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation | Intervention Type: DEVICE; Name: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: nitinol stent implantation; Assigned to Arm(s): standard PTA
D: Arm Label: Laser atherectomy and drug-coated balloon; Type: ACTIVE_COMPARATOR; Interventions: Device: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems | Arm Label: Drug eluting Ballon PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems | Intervention Type: DEVICE; Name: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems; Assigned to Arm(s): Drug eluting Ballon PTA, Laser atherectomy and drug-coated balloon

Answer: A